Hanlim Pharm. Co., Ltd.: Clinical Trials

58 trials sponsored by Hanlim Pharm. Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 17 unknown, 1 enrolling by invitation, 1 recruiting. 21 Phase 1, 13 Phase 3, 9 Phase 4, 6 Phase 2, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 121Completed 19, Unknown 2
Phase 313Completed 11, Recruiting 1, Unknown 1
Phase 49Completed 5, Unknown 4
Phase 26Completed 3, Unknown 3
Not applicable2Enrolling by invitation 1, Unknown 1

Follow Hanlim Pharm. Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.
LuminoMark inj. 0.2mL - Colorectal Cancer, Endoscopic Tattoo of Suspected Colon Cancer
Not applicableEnrolling by invitationSeoul St. Mary's Hospital302025-12-222026-02-02
Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
Test group, Exploratory test group, Control group 1 - Hypertension, Diabete Type 2
Phase 3RecruitingHanlim Pharm. Co., Ltd.2282025-12-182026-04-27
Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State
Test group 1, Test group 2 - Hypertension, Diabete Type 2
Phase 1CompletedHanlim Pharm. Co., Ltd.372024-10-162026-05-18
Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects
Crecheck Tablet 2.5 mg, Crestor Tablet 5 mg - Primary Hypercholesterolemia, Combined Hyperlipidemia
Phase 1CompletedHanlim Pharm. Co., Ltd.362023-11-202024-06-27
Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.
Vonoprazan Test 20mg, Vonoprazan Reference 20mg - Gastric Ulcer
Phase 1CompletedHanlim Pharm. Co., Ltd.302023-10-232024-10-16
Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection
Reversal of Neuromuscular Blockade
UnknownHanlim Pharm. Co., Ltd.15002023-07-212024-02-07
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers
Test group 1, Test group 2 - Hypertension, Diabete Type 2
Phase 1CompletedHanlim Pharm. Co., Ltd.352023-06-182026-05-20
Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease
Bronpass Tab., Placebo - Chronic Obstructive Pulmonary Disease
Phase 2UnknownHanlim Pharm. Co., Ltd.962023-06-012024-05-30
S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement
Essential Hypertension
UnknownHanlim Pharm. Co., Ltd.50002023-02-222023-11-14
Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops
Dry Eye Syndrome
UnknownHanlim Pharm. Co., Ltd.20002023-02-082023-12-15
The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab
Diabetes Mellitus, Type 2
UnknownHanlim Pharm. Co., Ltd.30002022-12-272024-02-15
Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients
Nicotinamide(Mitovita), Placebo - Glaucoma
Not applicableUnknownCHA University802022-09-162023-10-12
Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy
Entelon Tab. 50mg, Placebo - Non Proliferative Diabetic Retinopathy
Phase 4UnknownHanlim Pharm. Co., Ltd.3962022-05-272022-07-21
DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy
CompletedHanlim Pharm. Co., Ltd.5282022-05-192024-02-15
Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule
Bronpass Tab., Placebo of Erdos capsule, Erdos capsule - Acute Bronchitis
Phase 4CompletedKwang-Ha Yoo1102022-04-152023-09-14
An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)
Hypertension
UnknownHanlim Pharm. Co., Ltd.40002021-11-112024-01-22
Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive
BRIDIN-plus Eye drops, Combigan Eye drops - Glaucoma, Ocular Hypertensive
Phase 4CompletedCHA University602021-10-082025-03-26
An Observational Study on the Identification of Prescription Patterns of STAFEN Cap
Mixed Dyslipidemia
UnknownHanlim Pharm. Co., Ltd.40002021-04-212024-01-17
Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)
Entelon Tab.150mg, Venitol Tab., Placebo of Venitol Tab. - Chronic Venous Disease
Phase 4UnknownHanlim Pharm. Co., Ltd.2782021-01-282021-05-11
Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients
HL301 tablet 300mg, Placebo of HL301 tablet - Radiation Pneumonitis, Lung Cancer
Phase 2UnknownHanlim Pharm. Co., Ltd.872020-11-012020-11-17

Showing 20 of 58. Sign in to see all of them.

Conditions studied

Hypertension (7)  ·  Bronchitis (4)  ·  Diabetes Mellitus, Type 2 (4)  ·  Rhinitis, Allergic, Perennial (4)  ·  Arthritis, Rheumatoid (3)  ·  Dry Eye Syndromes (3)  ·  Glaucoma (3)  ·  Osteoporosis (3)  ·  Breast Diseases (2)  ·  Essential Hypertension (2)  ·  Pruritus (2)  ·  Colorectal Neoplasms (1)  ·  Diabetic Retinopathy (1)  ·  Lung Neoplasms (1)  ·  Osteoarthritis, Knee (1)

Interventions

Amlodipine (3)  ·  Amlodipine, Valsartan Drug Combination (3)  ·  Risedronic Acid (3)  ·  Rosuvastatin Calcium (3)  ·  Valsartan (3)  ·  levamlodipine (3)  ·  Brimonidine Tartrate (2)  ·  Celecoxib (2)  ·  Fenofibrate (2)  ·  Fluorescence (2)  ·  Telmisartan (2)  ·  pitavastatin (2)  ·  whole grape extract (2)  ·  Calcium Dobesilate (1)  ·  Chlorthalidone (1)

Countries

South Korea (52)  ·  France (1)

Top investigators

Hyoung-Moo Park, MD (2)  ·  KyoungSook Kim, PhD (2)  ·  Seungsoo Rho, MD, PhD (2)  ·  ChounKi Joo (1)  ·  David Bell (1)  ·  Ha Kyoung Kim (1)  ·  Heebaek Park (1)  ·  Ho-chan Cho (1)  ·  Jae Gook Shin, MD (1)  ·  Ji Young Park, Ph.D. (1)  ·  Ki-Bae Seung (1)  ·  Kisik Kim (1)

Results publications

PMID 11351356, PMID 24105252, PMID 29925421, PMID 32891418, PMID 33726718, PMID 41167798